积极清除血凝块与预防延迟性脑缺血降低动脉瘤性蛛网膜下腔出血后的延迟性脑梗死:16年患者登记研究结果
2015年后对高延迟性脑梗死风险患者逐步实施基于尿激酶和尼莫地平的四项主动清除血凝块与预防延迟性脑缺血方法(ABCD)。结果显示延迟性脑梗死发生率从21.2%降至7.7%,高血负荷患者神经功能结局显著改善。
要点
- ABCD实施后延迟性脑梗死发生率由21.2%降至7.7%(p<0.0001)。
- 高血负荷(Hijdra评分≥30)患者ABCD后26%达到mRS 0-3分,前为9%(p=0.006)。
- ABCD方法包括立体定向导管脑室脑池造瘘、终板开窗脑池脑室导管、脑室腰大池冲洗及腰腰冲洗。
核心结论
- 实施ABCD与低并发症率相关,并使每患者延迟性脑梗死负担下降70%。
- 高血负荷患者的神经功能结局显著改善。
研究设计与样本
- 后ABCD队列中9例参与ABCD随机试验并分配至标准治疗的患者被排除。
- 影像由独立委员会审核,梗死分类为早期、医源性或延迟性。
主要发现
- 后ABCD队列417例中139例(33.3%)被选择接受ABCD,外渗血量(Hijdra总和评分)是ABCD使用的关键因素。
- 延迟性脑梗死在前ABCD队列543例中发生115例(21.2%),在后ABCD队列417例中发生32例(7.7%)(p<0.0001)。
- 每患者延迟性脑梗死负担从38.6 cm³降至11.7 cm³。
- 高血负荷(Hijdra评分≥30)患者中,ABCD后26%达到改良Rankin量表评分0-3分,ABCD前为9%(p=0.006)。
临床怎么用
- 对动脉瘤性蛛网膜下腔出血后高延迟性脑梗死风险患者,可考虑基于尿激酶和尼莫地平实施ABCD。
- ABCD方法包括立体定向导管脑室脑池造瘘、经终板开窗脑池脑室导管、脑室腰大池冲洗及腰腰冲洗,需根据患者情况个体化选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Active clearance of intracranial blood by intrathecal irrigation, fibrinolysis, and application of vasodilatory drugs may prevent delayed cerebral infarction (DCI) after aneurysmal subarachnoid hemorrhage (aSAH). Starting in 2015, the authors gradually implemented four methods for active blood clearance and prevention of delayed cerebral ischemia (ABCD) using urokinase and nimodipine in clinical management. In this paper, the impact of a patient-tailored use of these methods on DCI prevention is reported. METHODS: Nine hundred sixty consecutive patients with aSAH admitted between 2008 and 2023 were included. Patients admitted before October 2015 were managed according to international guidelines (before-ABCD cohort, n = 543). ABCD became available in October 2015 and was gradually implemented by four different methods (after-ABCD cohort, n = 417) in patients at high risk for DCI. Nine patients in the after-ABCD cohort who were enrolled in a randomized trial on ABCD and allocated to standard of care were excluded. Cranial imaging was reviewed by an independent board and infarcts were classified as early, iatrogenic, or delayed. RESULTS: After October 2015, 139 (33.3%) of 417 patients were selected for ABCD and the amount of extravasated blood (Hijdra sum score) was the key factor for ABCD use. Stereotactic catheter ventriculocisternostomy was developed in October 2015 and used in 88 patients. Intraoperative placement of a cisternoventricular catheter via the fenestrated lamina terminalis was introduced in 2018 and used in 30 patients. In 2021, ventriculolumbar irrigation and lumbo-lumbar irrigation were developed and used in 18 and 3 patients, respectively. DCI occurred in 115 (21.2%) of 543 patients before versus 32 (7.7%) of 417 patients after ABCD implementation (p < 0.0001). The per-patient DCI burden declined from 38.6 to 11.7 cm3. Neurological outcome was improved in patients with a high blood load (Hijdra score ≥ 30), and 26% after ABCD versus 9% of patients before ABCD achieved a modified Rankin Scale score of 0-3 (p = 0.006). CONCLUSIONS: Implementation of ABCD was associated with a low complication rate and a decline of 70% in the per-patient DCI burden. Outcomes were significantly improved in patients with a high blood load.
引用
- Roelz R, Csók I, Overstijns M, et al. Decreasing delayed cerebral infarction after aneurysmal subarachnoid hemorrhage using active blood clearance and prevention of delayed cerebral ischemia: results of a 16-year patient registry. J Neurosurg. 2025. PMID: 40479830. doi:10.3171/2025.2.JNS242828
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。